These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7014873)

  • 21. D-penicillamine and the ocular myasthenic syndrome.
    Kimbrough RL; Mewis L; Stewart RH
    Ann Ophthalmol; 1981 Oct; 13(10):1171-2. PubMed ID: 7316342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penicillamine-induced myasthenia gravis in a patient with rheumatoid arthritis. A case report.
    Naidoo PD
    S Afr Med J; 1981 Sep; 60(12):478. PubMed ID: 7280897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Penicillamine-induced myasthenia in chronic rheumatoid arthritis (author's transl)].
    Seitz D; Hopf HC; Janzen RW; Meyer W
    Dtsch Med Wochenschr; 1976 Jul; 101(31):1153-8. PubMed ID: 976101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma exchange therapy for severe penicillamine-induced myasthenia gravis.
    Lang AE; Humphrey JG; Gordn DA
    J Rheumatol; 1981; 8(2):303-7. PubMed ID: 7230162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis.
    Marcus SN; Chadwick D; Walker RJ
    Gastroenterology; 1984 Jan; 86(1):166-8. PubMed ID: 6689658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ocular myasthenia caused by D-penicillamine (author's transl)].
    Schmidt D; Kommerell G
    Klin Monbl Augenheilkd; 1976 Mar; 168(3):409-13. PubMed ID: 966573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis.
    Raynauld JP; Lee YS; Kornfeld P; Fries JF
    J Rheumatol; 1993 Sep; 20(9):1592-3. PubMed ID: 8164222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myasthenia gravis induced by D-penicillamine].
    Berstad J
    Tidsskr Nor Laegeforen; 1983 Aug; 103(23):1646-7. PubMed ID: 6636079
    [No Abstract]   [Full Text] [Related]  

  • 32. [Myasthenia as a complication of D-penicillamine therapy of rheumatoid arthritis].
    Krikunov VP; Gubar' EE; Mogucheva IV; Shagal DI
    Ter Arkh; 1987; 59(4):139-41. PubMed ID: 3589994
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis.
    Devogelaer JP; Isaac G; Noël H; De Bruyère M; Huaux JP; Nagant de Deuxchaisnes C
    Int J Clin Pharmacol Res; 1985; 5(3):143-7. PubMed ID: 4018948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Letter: Myasthenia and autoimmune thyroiditis during rheumatoid polyarthritis treated by D-penicillamine].
    Delrieu F; Menkes CJ; Sainte-Croix A; Delbarre F; Babinet P; Chesneau AM
    Nouv Presse Med; 1975 Nov; 4(40):2890(1). PubMed ID: 1215207
    [No Abstract]   [Full Text] [Related]  

  • 35. [Myasthenia caused by D-penicillamine in rheumatoid arthritis].
    Héraud A; Dromer C; Fatout E; Fournié B; Fournié A
    Rev Rhum Ed Fr; 1994 Jan; 61(1):59-60. PubMed ID: 8000404
    [No Abstract]   [Full Text] [Related]  

  • 36. [D-penicillamine-induced myasthenia gravis].
    Murros K; Möttönen T
    Duodecim; 1984; 100(5):292-4. PubMed ID: 6714116
    [No Abstract]   [Full Text] [Related]  

  • 37. [Myasthenia gravis pseudoparalytica as a result of penicillamine treatment of rheumatoid arthritis].
    Gietka A
    Reumatologia; 1982; 20(1-2):65-8. PubMed ID: 7163666
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acetylcholine receptor antibody in D-penicillamine therapy].
    Kolarz G; Maida EM
    Z Rheumatol; 1986; 45(3):118-21. PubMed ID: 3751350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myasthenia gravis and autoimmune thyroiditis during the treatment of rheumatoid polyarthritis withD-penicillamine. Anatomoclinical study of 1 case].
    Delrieu F; Menkes CJ; Sainte-Croix A; Babinet P; Chesneau AM; Delbarre F
    Ann Med Interne (Paris); 1976 Oct; 127(10):739-43. PubMed ID: 1008366
    [No Abstract]   [Full Text] [Related]  

  • 40. [Myasthenia gravis associated with penicillamine treatment].
    Medrano San Ildefonso M; Mauri Llerda JA; Orte Martínez J
    Arch Neurobiol (Madr); 1987; 50(4):272-3. PubMed ID: 3662740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.